← Open Payments lookup

JOHN BILLON: Open Payments

NPI 1083714653 · ARNOLD, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,038 in 92 payments from 25 companies in 2025. Trend: 2023 $1,711 · 2024 $1,449 · 2025 $2,038

Food & beverage: $2,038
CompanyPaymentsAmount
Novo Nordisk Inc22$505
ABBVIE INC.12$268
Lilly USA, LLC14$240
Astellas Pharma US Inc5$136
Madrigal Pharmaceuticals1$108
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$105
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$86
PFIZER INC.3$67
Exact Sciences Corporation3$65
AstraZeneca Pharmaceuticals LP3$59

Products named: Rybelsus, Wegovy, VRAYLAR, MOUNJARO, Ozempic, Veozah, REZDIFFRA, XIFAXAN.

Industry payments across MD — which companies pay providers there.